Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raman Baweja

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Journal of Affective Disorders|April 1, 2026
Association of SGLT2 inhibitors with suicidality, all-cause mortality, and hospitalization in bipolar disorder: A cohort study of 1.23 million adultsBalwinder Singh, Raman Baweja
The American Journal of Psychiatry|September 14, 2013
Concomitant use of maintenance ECT and vagus nerve stimulation for more than 10 years in treatment-resistant depressionRaman Baweja, Ravi Singareddy
Journal of Child and Adolescent Psychopharmacology|August 20, 2013
A case of severe akathisia with atomoxetineRaman Baweja, Lidija Petrovic-Dovat
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2025
Editorial: The Promise of Precision Medicine in Pediatric Attention-Deficit/Hyperactivity Disorder: Are We Ready to Deliver?Raman Baweja, James G Waxmonsky
European Archives of Psychiatry and Clinical Neuroscience|September 27, 2020
The role of neurotropism in psychiatric patients with COVID-19Ailyn D Diaz, Raman Baweja
Journal of the American Academy of Child and Adolescent Psychiatry|March 9, 2019
Editorial: Does an Attention-Deficit/Hyperactivity Disorder Pill a Day Keep Failing Grades Away?James G Waxmonsky, Raman Baweja
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity DisorderRaman Baweja, James G Waxmonsky
The Primary Care Companion for CNS Disorders|October 7, 2022
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control StudyAilyn D Diaz, Raman Baweja
Journal of Clinical Psychopharmacology|October 5, 2018
Withdrawal-Emergent Dyskinesia After Acute Discontinuation of Risperidone in a Child With Autism Spectrum DisorderMaanvi Kumar, Richard Mattison, Raman Baweja
Clinical Neuropharmacology|April 3, 2021
Steroids With Risperidone: Is it Really a New Frontier in the Treatment of Autism Spectrum Disorders Among Children and Adolescents?Chintan Trivedi, Zeeshan Mansuri, Raman Baweja
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Journal of Affective Disorders|April 1, 2026
Association of SGLT2 inhibitors with suicidality, all-cause mortality, and hospitalization in bipolar disorder: A cohort study of 1.23 million adultsBalwinder Singh, Raman Baweja
The American Journal of Psychiatry|September 14, 2013
Concomitant use of maintenance ECT and vagus nerve stimulation for more than 10 years in treatment-resistant depressionRaman Baweja, Ravi Singareddy
Journal of Child and Adolescent Psychopharmacology|August 20, 2013
A case of severe akathisia with atomoxetineRaman Baweja, Lidija Petrovic-Dovat
Journal of the American Academy of Child and Adolescent Psychiatry|August 23, 2025
Editorial: The Promise of Precision Medicine in Pediatric Attention-Deficit/Hyperactivity Disorder: Are We Ready to Deliver?Raman Baweja, James G Waxmonsky
European Archives of Psychiatry and Clinical Neuroscience|September 27, 2020
The role of neurotropism in psychiatric patients with COVID-19Ailyn D Diaz, Raman Baweja
Journal of the American Academy of Child and Adolescent Psychiatry|March 9, 2019
Editorial: Does an Attention-Deficit/Hyperactivity Disorder Pill a Day Keep Failing Grades Away?James G Waxmonsky, Raman Baweja
Child and Adolescent Psychiatric Clinics of North America|June 13, 2022
Updates in Pharmacologic Strategies for Emotional Dysregulation in Attention Deficit Hyperactivity DisorderRaman Baweja, James G Waxmonsky
The Primary Care Companion for CNS Disorders|October 7, 2022
Protective Effect of Fluvoxamine for COVID-19 in Obsessive-Compulsive Disorder: A Real-World Case-Control StudyAilyn D Diaz, Raman Baweja
Journal of Clinical Psychopharmacology|October 5, 2018
Withdrawal-Emergent Dyskinesia After Acute Discontinuation of Risperidone in a Child With Autism Spectrum DisorderMaanvi Kumar, Richard Mattison, Raman Baweja
Clinical Neuropharmacology|April 3, 2021
Steroids With Risperidone: Is it Really a New Frontier in the Treatment of Autism Spectrum Disorders Among Children and Adolescents?Chintan Trivedi, Zeeshan Mansuri, Raman Baweja
Pageof 9